Descripción de negocio
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Consejo de gestión & Consejo de supervisión
CEO |
Guillaume Daniellot |
Consejo de gestión |
Dr. Peter Hackel, Camila Finzi, Wolfgang Becker, Jason Forbes , Holger Haderer, Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Rahma Samow, Matthias Schupp, Dr Christian Ullrich |
Consejo de supervisión |
Petra Rumpf, Dr. Beat Lüthi, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol, Regula Wallimann |
Datos de la empresa
Nombre: |
Straumann Holding AG |
Dirección: |
Peter Merian-Weg 12,CH-4052 Basel |
Teléfono: |
+41-61-965-1111 |
Fax: |
+41-61-965-1101 |
E-mail: |
info@straumann.com
|
Internet: |
www.straumann.com |
Industria: |
Healthcare |
Sector: |
Medical Products |
Subsector: |
Advanced Medical Devices |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
57.90% |
Fecha de OPI: |
01/01/1998 |